Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Assistance Publique - Hôpitaux de Paris
This is a multicenter, randomised, double-blind controlled trial, comparing amoxicillin-clavulanic acid administered for 7 days to a placebo.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients included are those with documented or suspected COLD, exclusive of other bronchial or lung disease, and admitted for acute exacerbation, in the absence of overt sepsis or broncho-pneumonia, and having no other organ.
You may not be if
Patients recently hospitalised, having received antibiotics since more than 24h, or on long-term steroids will not be included
Clareo Health | ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPD
